The use of the in vitro micronucleus assay to detect and assess the aneugenic activity of chemicals.
The successful validation of the in vitro micronucleus assay by the SFTG now provides the opportunity for this highly cost effective assay to be used to screen chemicals for their ability to induce both structural (clastogenic) and numerical (aneugenic) chromosome changes using interphase cells. The use of interphase cells and a relatively simple experimental protocol provides the opportunity to greatly increase the statistical power of cytogenetic studies on chemical interactions. The application of molecular probes capable of detecting kinetochores and centromeres provides the opportunity to classify mechanisms of micronucleus induction into those which are primarily due to chromosome loss or breakage. When a predominant mechanism of micronucleus induction has been shown to be based upon chromosome loss then further investigation can involve the determination of the role of non-disjunction in the induction of aneuploidy. The binucleate cell modification of the in vitro micronucleus assay can be combined with the use of chromosome specific centromere probes to determine the segregation of individual chromosomes into daughter nuclei. The combination of these methods provides us with powerful tools for the investigation of mechanisms of genotoxicity particularly in the low dose regions.
Parry
James M
JM
Parry
Elizabeth M
EM
D024422:Aneugens / Q000633:toxicity*; D000782:Aneuploidy; D017408:Guidelines as Topic; D006801:Humans; D015162:Micronucleus Tests / Q000592:standards; D009630:Nondisjunction, Genetic; D015203:Reproducibility of Results; D006113:United Kingdom
D024422:Aneugens